𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of zonisamide on tardive dyskinesia: A preliminary open-label trial

✍ Scribed by Yusuke Iwata; Sachiko Irie; Hiroyuki Uchida; Takefumi Suzuki; Koichiro Watanabe; Satoru Iwashita; Masaru Mimura

Book ID
119304395
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
150 KB
Volume
315
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A pilot open-label trial of zonisamide i
A pilot open-label trial of zonisamide in Unverricht-Lundborg disease
✍ Domenico Italiano; Marianna Pezzella; Antonietta Coppola; Adriana Magaudda; Edoa πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 629 KB

We compared the frequency of rhinorrhea between 34 Parkinson's disease (PD) subjects and 15 normal controls (NC) and explored relationships between rhinorrhea and clinical functions, and degree of nigrostriatal dopaminergic denervation using [ 11 C]dihydrotetrabenazine (DTBZ) brain positron emission

Effect of co-dergocrine mesylate on tard
Effect of co-dergocrine mesylate on tardive dyskinesia a preliminary report
✍ Jack Hajioff; Mackenzie Wallace πŸ“‚ Article πŸ“… 1983 πŸ› Springer 🌐 English βš– 265 KB

Twenty patients with signs of tardive dyskinesia secondary to antipsychotic medication participated in a double blind, controlled, parallel group study comparing codergocrine mesylate 4.5 mg once daily with a placebo. After 6 weeks medication a reduction in dyskinetic scores occurred in both groups,